MEDIAN TECHNOLOGIES (EPA:ALMDT) | WebDisclosure

Basculer en Français

10066	Companies
205772	Keywords
136030	Articles
109102	Press releases

Home
Companies
MEDIAN TECHNOLOGIES

BRIEF

published on 02/09/2026 at 07:05, 1 month 14 days ago

FDA Clearance Granted for Median Technologies' AI-based Lung Cancer Device

FDA Clearance AI Technology Lung Cancer Screening Eyonis® LCS Reimbursement Pathway
BRIEF

published on 02/09/2026 at 07:05, 1 month 14 days ago

Median Technologies reçoit l'autorisation 510(k) de la FDA pour eyonis® LCS

FDA Technologie IA Median Technologies Eyonis® LCS Dépistage Cancer Poumon
BRIEF

published on 02/09/2026 at 07:05, 1 month 14 days ago

Median Technologies receives FDA 510(k) clearance for eyonis® LCS

FDA AI Technology Median Technologies Lung Cancer Screening Eyonis® LCS
BRIEF

published on 02/09/2026 at 07:05, 1 month 14 days ago

Autorisation de la FDA accordée au dispositif de dépistage du cancer du poumon basé sur l'IA de Median Technologies

Technologie IA Autorisation De La FDA Dépistage Du Cancer Du Poumon Eyonis® LCS Voie De Remboursement
PRESS RELEASE

published on 02/09/2026 at 07:00, 1 month 14 days ago

Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
Median Technologies obtient l'autorisation 510(k) de la FDA pour eyonis® LCS, logiciel IA dépistage cancer poumon. Nouveau paradigme dépistage. Déploiement à grande échelle en cours

Dépistage Median Technologies Cancer Du Poumon Autorisation 510(k) Eyonis® LCS
PRESS RELEASE

published on 02/09/2026 at 07:00, 1 month 14 days ago

Inside Information / Operations of the issuer (acquisitions, sales...)
Median Technologies receives FDA 510(k) clearance for eyonis® LCS, the first AI tech-based detection and diagnosis device for lung cancer screening. The device aims to redefine lung cancer screening with high accuracy and potential to save lives

FDA Clearance AI Technology Median Technologies Eyonis LCS Lung Cancer Screening
BRIEF

published on 01/14/2026 at 17:50, 2 months 8 days ago

Median Technologies: Financial Calendar and Conference Participation in 2026

Investor Conferences Financial Calendar Annual Results Median Technologies AI-powered Medical Imaging
BRIEF

published on 01/14/2026 at 17:50, 2 months 8 days ago

Median Technologies : Calendrier Financier et Participation à des Conférences en 2026

Calendrier Financier Résultats Annuels Conférences Investisseurs Median Technologies Imagerie Médicale IA
PRESS RELEASE

published on 01/14/2026 at 17:45, 2 months 8 days ago

Informations privilégiées / Autres communiqués
Median Technologies communique son calendrier de communication financière du premier semestre 2026, incluant les résultats annuels 2025 et la participation à des conférences investisseurs

Communication Financière Intelligence Artificielle Conférences Investisseurs Calendrier Median Technologies
BRIEF

published on 12/03/2025 at 17:50, 3 months 19 days ago

Median Technologies révèle la structure des droits de vote et du capital social

Capital Social Droit De Vote Conformité Réglementaire Transparence Financière Technologies Médianes

Accesswire

Published on 03/23/2026 at 14:05, 2 hours 34 minutes ago

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 2 hours 39 minutes ago

BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 3 hours 34 minutes ago

SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 4 hours 7 minutes ago

Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 4 hours 9 minutes ago

Digi Power X to Announce 2025 Year End Financial Results on March 31st

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 16:20, 19 minutes ago

Switzerland Remove Niels Troost from Sanctions
Published on 03/23/2026 at 15:05, 1 hour 34 minutes ago

Heidrick & Struggles Launches Heidrick Immersive, an AI-Enhanced Platform for Observing Leadership in Motion
Published on 03/23/2026 at 14:41, 1 hour 58 minutes ago

CEWE increases dividend for 17 consecutive years
Published on 03/23/2026 at 14:30, 2 hours 9 minutes ago

Solvias Earns EcoVadis Bronze Medal, Ranking in Top 35% of Companies for Sustainability Performance
Published on 03/23/2026 at 14:30, 2 hours 9 minutes ago

Belvilla Expands in Germany with Hambachtal Holiday Park in Oberhambach

Les Echos

Published on 03/23/2026 at 08:10, 8 hours 29 minutes ago

Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 21 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 21 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 22 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 22 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA

View all LES ECHOS COMFI WIRE